CN111724841B - An information storage method based on biological protein - Google Patents
An information storage method based on biological protein Download PDFInfo
- Publication number
- CN111724841B CN111724841B CN202010500300.1A CN202010500300A CN111724841B CN 111724841 B CN111724841 B CN 111724841B CN 202010500300 A CN202010500300 A CN 202010500300A CN 111724841 B CN111724841 B CN 111724841B
- Authority
- CN
- China
- Prior art keywords
- biological protein
- information
- biological
- storage method
- information storage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 137
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 137
- 238000003860 storage Methods 0.000 title claims abstract description 40
- 238000000034 method Methods 0.000 title claims abstract description 38
- 239000012528 membrane Substances 0.000 claims abstract description 85
- 125000000524 functional group Chemical group 0.000 claims abstract description 21
- 239000004365 Protease Substances 0.000 claims description 19
- 239000000758 substrate Substances 0.000 claims description 18
- 108010022355 Fibroins Proteins 0.000 claims description 15
- 239000007769 metal material Substances 0.000 claims description 14
- 239000012460 protein solution Substances 0.000 claims description 14
- 239000003242 anti bacterial agent Substances 0.000 claims description 13
- 229940088710 antibiotic agent Drugs 0.000 claims description 13
- 239000000090 biomarker Substances 0.000 claims description 10
- 230000005855 radiation Effects 0.000 claims description 10
- 108091005804 Peptidases Proteins 0.000 claims description 9
- 238000000862 absorption spectrum Methods 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 8
- 238000004528 spin coating Methods 0.000 claims description 8
- -1 ITO Inorganic materials 0.000 claims description 7
- 230000000844 anti-bacterial effect Effects 0.000 claims description 7
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 5
- 239000002105 nanoparticle Substances 0.000 claims description 5
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 claims description 4
- 229910017083 AlN Inorganic materials 0.000 claims description 4
- 102000008186 Collagen Human genes 0.000 claims description 4
- 108010035532 Collagen Proteins 0.000 claims description 4
- 102000002322 Egg Proteins Human genes 0.000 claims description 4
- 108010000912 Egg Proteins Proteins 0.000 claims description 4
- 229910001218 Gallium arsenide Inorganic materials 0.000 claims description 4
- 102000035195 Peptidases Human genes 0.000 claims description 4
- 108010013296 Sericins Proteins 0.000 claims description 4
- 229920001872 Spider silk Polymers 0.000 claims description 4
- 229920001436 collagen Polymers 0.000 claims description 4
- 235000014103 egg white Nutrition 0.000 claims description 4
- 210000000969 egg white Anatomy 0.000 claims description 4
- 239000011521 glass Substances 0.000 claims description 4
- 239000003102 growth factor Substances 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000002096 quantum dot Substances 0.000 claims description 4
- 229910018072 Al 2 O 3 Inorganic materials 0.000 claims description 3
- 229910004298 SiO 2 Inorganic materials 0.000 claims description 3
- 108010076876 Keratins Proteins 0.000 claims 1
- 102000011782 Keratins Human genes 0.000 claims 1
- 238000011065 in-situ storage Methods 0.000 abstract description 4
- 230000000694 effects Effects 0.000 description 14
- 108090000526 Papain Proteins 0.000 description 10
- 238000010521 absorption reaction Methods 0.000 description 10
- 235000019834 papain Nutrition 0.000 description 10
- 229940055729 papain Drugs 0.000 description 10
- 238000010586 diagram Methods 0.000 description 9
- 102000009027 Albumins Human genes 0.000 description 8
- 108010088751 Albumins Proteins 0.000 description 8
- 102000001554 Hemoglobins Human genes 0.000 description 8
- 108010054147 Hemoglobins Proteins 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 229910052804 chromium Inorganic materials 0.000 description 6
- 229910052737 gold Inorganic materials 0.000 description 6
- 230000003287 optical effect Effects 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 125000004383 glucosinolate group Chemical group 0.000 description 4
- 235000019419 proteases Nutrition 0.000 description 4
- 239000000523 sample Substances 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229910008599 TiW Inorganic materials 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000001459 lithography Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 238000010079 rubber tapping Methods 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 238000012876 topography Methods 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 241000255789 Bombyx mori Species 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 238000001898 apertureless near-field scanning optical microscopy Methods 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229910052681 coesite Inorganic materials 0.000 description 1
- 229910052593 corundum Inorganic materials 0.000 description 1
- 229910052906 cristobalite Inorganic materials 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000003989 dielectric material Substances 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000007306 functionalization reaction Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000002164 ion-beam lithography Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 238000005329 nanolithography Methods 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229910052682 stishovite Inorganic materials 0.000 description 1
- 229910052905 tridymite Inorganic materials 0.000 description 1
- 229910001845 yogo sapphire Inorganic materials 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G11—INFORMATION STORAGE
- G11C—STATIC STORES
- G11C11/00—Digital stores characterised by the use of particular electric or magnetic storage elements; Storage elements therefor
- G11C11/54—Digital stores characterised by the use of particular electric or magnetic storage elements; Storage elements therefor using elements simulating biological cells, e.g. neuron
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Computer Hardware Design (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
技术领域technical field
本发明涉及信息存储领域,具体涉及一种基于生物蛋白的信息存储方法。The invention relates to the field of information storage, in particular to an information storage method based on biological proteins.
背景技术Background technique
在过去的二十年中,信息存储已开发出许多策略,其中包括:将深紫外或远紫外光源,双光束系统和3D存储架构,以将光存储密度提高到数百Gb/inch2。然而,为了获得高空间分辨率,这些方法中的许多不可避免地涉及时间和成本低效率的复杂过程。此外,它们使用常规的光学器件,该光学器件受到衍射极限的限制,并且不能将存储密度提高到远高于当前的工业标准。Over the past two decades, many strategies have been developed for information storage, including: deep-ultraviolet or far-ultraviolet light sources, dual-beam systems, and 3D storage architectures to increase optical storage densities to hundreds of Gb/inch2. However, in order to obtain high spatial resolution, many of these methods inevitably involve time- and cost-inefficient complex procedures. Furthermore, they use conventional optics, which are limited by the diffraction limit and cannot increase storage densities much higher than current industry standards.
散射型扫描近场光学显微镜最初用于实现超出衍射极限的超分辨率成像,为促进高分辨率纳米加工提供了一种有前途的替代策略。利用光学介质(例如,光敏基板或纳米粒子)与极端亚波长尺度的入射光之间的近场电磁相互作用,为利用光致效应进行纳米制造和操纵铺平了道路。例如,可以使用光纤或具有超尖尖端的扫描金属探针(或探针阵列)通过倏逝场的高光能密度来诱发非线性光学现象。倏逝场可用于处理材料表面的纳米级区域,光学纳米器件的制造以及纳米光刻。Scattering-type scanning near-field optical microscopy was originally used to achieve super-resolution imaging beyond the diffraction limit, providing a promising alternative strategy to facilitate high-resolution nanofabrication. Harnessing the near-field electromagnetic interactions between optical media (e.g., photosensitive substrates or nanoparticles) and incident light at extreme subwavelength scales paves the way for nanofabrication and manipulation using photoinduced effects. For example, nonlinear optical phenomena can be induced by the high optical energy density of evanescent fields using optical fibers or scanning metal probes (or probe arrays) with ultra-sharp tips. Evanescent fields can be used to treat nanoscale regions of material surfaces, fabrication of optical nanodevices, and nanolithography.
为了提高光刻效率,进而提高信息存储过程的效率,必须协同考虑介质材料,入射光的波长以及探针的尖端尺寸和材料。具体而言,介质中的光刻模式(包括光诱导,热诱导,电诱导和应力/应变诱导的相变)实际上取决于材料。在这种情况下,丝素蛋白(一种来自家蚕的天然存在的蛋白质)因其机械强度,光学透明性,生物相容性,生物降解性和可调的水溶性而广受赞赏。由于该材料可以经历辐射诱导的纳米级多晶型转变,因此已被用作抗蚀剂-薄层,用于通过电子束,离子束光刻将电路图案转移到半导体衬底上。然而,这些现有的光刻方法通常在高真空下操作或依赖于基于掩模的转移方法。In order to improve the efficiency of lithography, and thus the efficiency of the information storage process, the dielectric material, the wavelength of the incident light, and the tip size and material of the probe must be taken into consideration in synergy. Specifically, the lithographic modes in the medium, including photo-induced, thermally-induced, electrical-induced and stress/strain-induced phase transitions, are actually material dependent. In this context, silk fibroin, a naturally occurring protein from the silkworm, is widely appreciated for its mechanical strength, optical transparency, biocompatibility, biodegradability, and tunable water solubility. Because the material can undergo radiation-induced nanoscale polymorphic transitions, it has been used as a resist-thin layer for transferring circuit patterns onto semiconductor substrates by electron beam, ion beam lithography. However, these existing lithography methods typically operate under high vacuum or rely on mask-based transfer methods.
此外,在今天的信息时代,信息的形式纷繁多样,信息的记录存储方式也随之不断改进。然而,受限于信息存储的介质,当前的信息存储器主要用于存储物理信息,而不适合存储随时间变化的带有活性(bio-active)的生物信息(biology-basedinformation)。In addition, in today's information age, the forms of information are various, and the way of recording and storing information is also constantly improving. However, limited by the information storage medium, the current information storage is mainly used to store physical information, and is not suitable for storing biological-based information with bio-active changes over time.
丝素蛋白也是一种生物兼容性良好、易于掺杂功能化、并且易于纳米加工的生物材料,将丝素蛋白用作信息存储的媒质,不仅可以实现物理信息的存储(即通过表面纳米结构存储编码化的数据);未来还可以通过生命体与丝素蛋白之间的交互作用,存储、解析生命体的信息。Silk fibroin is also a biomaterial with good biocompatibility, easy doping and functionalization, and easy nanofabrication. Using silk fibroin as a medium for information storage can not only achieve physical information storage (that is, storage through surface nanostructures). Encoded data); in the future, the information of living organisms can also be stored and analyzed through the interaction between living organisms and silk fibroin.
但是如何利用丝素蛋白存储信息是本领域技术人所亟需解决的。However, how to use silk fibroin to store information is an urgent need for those skilled in the art.
发明内容SUMMARY OF THE INVENTION
针对现有技术的上述问题,本发明的目的在于提供一种基于生物蛋白的信息存储方法,能够存储生物信息,能够原位“写入”和“读取”数字化信息,能够实现数字化信息的重复写入或擦除,同时能够耐受高温、高湿度、辐照、磁场等恶劣条件。In view of the above problems of the prior art, the purpose of the present invention is to provide an information storage method based on biological proteins, which can store biological information, "write" and "read" digital information in situ, and realize the repetition of digital information. Write or erase, while being able to withstand harsh conditions such as high temperature, high humidity, radiation, and magnetic fields.
为了解决上述问题,本发明提供一种基于生物蛋白的信息存储方法,包括以下步骤:In order to solve the above problems, the present invention provides a biological protein-based information storage method, comprising the following steps:
S1.制备掺杂或未掺杂功能基团的生物蛋白膜;S1. Preparation of biological protein membranes doped or undoped with functional groups;
S2.对待存储信息进行编码;S2. Encode the information to be stored;
S3.将编码后的信息以及功能基团中的信息存储于所述生物蛋白膜中。S3. Store the encoded information and the information in the functional group in the biological protein membrane.
进一步地,步骤S1包括以下步骤:Further, step S1 includes the following steps:
S11.在基底上蒸发一层金属材料;S11. Evaporate a layer of metal material on the substrate;
S12.在蒸发有所述金属材料的基底上旋涂一层生物蛋白溶液,形成生物蛋白膜。S12. Spin coating a layer of biological protein solution on the substrate on which the metal material is evaporated to form a biological protein film.
进一步地,所述基底为Si、GaAs、AlN、Al2O3、ITO、SiO2、SiN、玻璃材料中的一种;Further, the substrate is one of Si, GaAs, AlN, Al2O3, ITO, SiO2, SiN, and glass materials;
所述生物蛋白为丝素蛋白、丝胶蛋白、蛛丝蛋白、鹿角蛋白、蛋清蛋白、胶原蛋白中的一种。The biological protein is one of silk fibroin, sericin, spider silk, staghorn, egg white and collagen.
进一步地,所述生物蛋白溶液中可预先掺有功能基团,所述功能基团为生物标记物、DNA、量子点、抗生素、纳米颗粒、生长因子、蛋白酶、抗体中的一种或几种。Further, the biological protein solution can be pre-mixed with functional groups, and the functional groups are one or more of biomarkers, DNA, quantum dots, antibiotics, nanoparticles, growth factors, proteases, and antibodies. .
进一步地,所述生物蛋白膜中掺入生物标记物、DNA后,能够储存生物相关信息。Further, after incorporating biomarkers and DNA into the biological protein membrane, biological-related information can be stored.
进一步地,所述生物蛋白膜中掺入抗生素后,能够抗菌。Further, after incorporating antibiotics into the biological protein membrane, it can be antibacterial.
进一步地,所述生物蛋白膜中掺入蛋白酶后,存储的信息能够可控降解。Further, after the protease is incorporated into the biological protein membrane, the stored information can be degraded in a controllable manner.
进一步地,步骤S2包括:Further, step S2 includes:
将待存储信息按照预设编码形式进行编码。The information to be stored is encoded according to the preset encoding form.
进一步地,步骤S3包括以下步骤:Further, step S3 includes the following steps:
S31.采用预设功率的激光源辐射原子力显微镜的针尖,所述激光源辐射频率与所述生物蛋白膜的吸收光谱相对应;S31. Use a laser source of preset power to irradiate the needle tip of an atomic force microscope, and the radiation frequency of the laser source corresponds to the absorption spectrum of the biological protein membrane;
S32.移动所述生物蛋白膜,在所述生物蛋白膜上直写编码后的信息对应的点阵结构。S32. Move the biological protein membrane, and directly write the lattice structure corresponding to the encoded information on the biological protein membrane.
进一步地,在步骤S32之后,所述方法还包括:Further, after step S32, the method further includes:
对存储于所述生物蛋白膜中的信息进行解码,读取存储于所述生物蛋白膜中的信息。Decoding the information stored in the biological protein membrane, and reading the information stored in the biological protein membrane.
进一步地,所述对存储于所述生物蛋白膜中的信息进行解码,读取存储于所述生物蛋白膜中的信息包括:Further, decoding the information stored in the biological protein membrane, and reading the information stored in the biological protein membrane includes:
采用原子力显微镜扫描所述点阵结构,对所述点阵结构中的信息进行解码,读取所述点阵结构中的信息。The lattice structure is scanned by an atomic force microscope, the information in the lattice structure is decoded, and the information in the lattice structure is read.
进一步地,在步骤S32之后,所述方法还包括:Further, after step S32, the method further includes:
对存储于所述生物蛋白膜中的信息进行擦除,重写存储于所述生物蛋白膜中的信息。The information stored in the biological protein membrane is erased, and the information stored in the biological protein membrane is rewritten.
进一步地,所述对存储于所述生物蛋白膜中的信息进行擦除,重写存储于所述生物蛋白膜中的信息包括:Further, erasing the information stored in the biological protein membrane, and rewriting the information stored in the biological protein membrane includes:
采用小于或大于所述预设功率的红外激光源辐射原子力显微镜的针尖,对所述点阵结构进行消除,Using an infrared laser source with a power smaller than or greater than the preset power to irradiate the tip of the atomic force microscope to eliminate the lattice structure,
采用所述预设功率的红外激光源辐射原子力显微镜的针尖,重写所述点阵结构。Using the infrared laser source with the preset power to irradiate the tip of an atomic force microscope, the lattice structure is rewritten.
由于上述技术方案,本发明具有以下有益效果:Due to the above-mentioned technical scheme, the present invention has the following beneficial effects:
本发明的一种基于生物蛋白的信息存储方法,能够存储生物信息,能够原位“写入”和“读取”数字化信息,能够实现数字化信息的重复写入或擦除,同时能够耐受高温、高湿度、辐照、磁场等恶劣条件。The biological protein-based information storage method of the present invention can store biological information, "write" and "read" digital information in situ, realize repeated writing or erasing of digital information, and can withstand high temperature at the same time. , high humidity, radiation, magnetic fields and other harsh conditions.
附图说明Description of drawings
为了更清楚地说明本发明的技术方案,下面将对实施例或现有技术描述中所需要使用的附图作简单的介绍。显而易见地,下面描述中的附图仅仅是本发明的一些实施例,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其它附图。In order to illustrate the technical solutions of the present invention more clearly, the following will briefly introduce the accompanying drawings that are required to be used in the description of the embodiments or the prior art. Obviously, the drawings in the following description are only some embodiments of the present invention, and for those of ordinary skill in the art, other drawings can also be obtained from these drawings without creative effort.
图1是本发明实施例提供的基于生物蛋白的信息存储方法的流程图;1 is a flowchart of a biological protein-based information storage method provided in an embodiment of the present invention;
图2是本发明实施例提供的步骤S1的流程图;2 is a flowchart of step S1 provided by an embodiment of the present invention;
图3是本发明实施例提供的步骤S3的流程图;3 is a flowchart of step S3 provided by an embodiment of the present invention;
图4是本发明实施例一提供的点阵结构的示意图;4 is a schematic diagram of a lattice structure provided in
图5是本发明实施例一提供的点阵结构的局部示意图;5 is a partial schematic diagram of a lattice structure provided in
图6是本发明实施例二提供的点阵结构的示意图;6 is a schematic diagram of a lattice structure provided by Embodiment 2 of the present invention;
图7是本发明实施例二提供的已经消除处理的点阵结构的示意图。FIG. 7 is a schematic diagram of a lattice structure that has been eliminated and processed according to Embodiment 2 of the present invention.
图8是本发明实施例提供的掺入生物标记物和DNA的生物蛋白膜归一化活性的对比图;Figure 8 is a comparison diagram of the normalization activity of biological protein membranes incorporating biomarkers and DNA provided by the embodiment of the present invention;
图9是本发明实施例提供的掺入生物标记物和DNA的生物蛋白膜信息数量的对比图;Figure 9 is a comparison diagram of the amount of biological protein membrane information incorporated into biomarkers and DNA provided in an embodiment of the present invention;
图10是本发明实施例提供的掺入抗生素的生物蛋白膜抗菌性能的对比图。FIG. 10 is a comparison diagram of the antibacterial performance of the biological protein membrane incorporating antibiotics provided in the embodiment of the present invention.
图11是本发明实施例提供的掺入蛋白酶的生物蛋白膜降解性能的对比图;Figure 11 is a comparison diagram of the degradation performance of the biological protein membrane incorporating protease provided in the embodiment of the present invention;
图12是本发明实施例提供的生物蛋白膜的其他性能对比图。FIG. 12 is a comparison diagram of other properties of the biological protein membrane provided in the embodiment of the present invention.
具体实施方式Detailed ways
下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动的前提下所获得的所有其他实施例,都属于本发明保护的范围。The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings in the embodiments of the present invention. Obviously, the described embodiments are only a part of the embodiments of the present invention, but not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those of ordinary skill in the art without creative work fall within the protection scope of the present invention.
此处所称的“一个实施例”或“实施例”是指可包含于本发明至少一个实现方式中的特定特征、结构或特性。在本发明的描述中,需要理解的是,术语“上”、“下”等指示的方位或位置关系为基于附图所示的方位或位置关系,仅是为了便于描述本发明和简化描述,而不是指示或暗示所指的装置或元件必须具有特定的方位、以特定的方位构造和操作,因此不能理解为对本发明的限制。Reference herein to "one embodiment" or "an embodiment" refers to a particular feature, structure, or characteristic that may be included in at least one implementation of the present invention. In the description of the present invention, it should be understood that the orientation or positional relationship indicated by the terms "upper", "lower", etc. is based on the orientation or positional relationship shown in the accompanying drawings, and is only for the convenience of describing the present invention and simplifying the description, It is not intended to indicate or imply that the device or element referred to must have a particular orientation, be constructed and operate in a particular orientation, and therefore should not be construed as limiting the invention.
实施例一Example 1
本实施例一提供了一种基于生物蛋白的信息存储方法,结合图1、图2和图3所示,包括以下步骤:The first embodiment provides a biological protein-based information storage method, which is shown in FIG. 1 , FIG. 2 and FIG. 3 , and includes the following steps:
S1.制备掺杂或未掺杂功能基团的生物蛋白膜;S1. Preparation of biological protein membranes doped or undoped with functional groups;
S2.对待存储信息进行编码;S2. Encode the information to be stored;
S3.将编码后的信息以及功能基团中的信息存储于所述生物蛋白膜中。S3. Store the encoded information and the information in the functional group in the biological protein membrane.
具体地,步骤S1包括以下步骤:Specifically, step S1 includes the following steps:
S11.在基底上蒸发一层金属材料;S11. Evaporate a layer of metal material on the substrate;
S12.在蒸发有所述金属材料的基底上旋涂一层生物蛋白溶液,形成生物蛋白膜。S12. Spin coating a layer of biological protein solution on the substrate on which the metal material is evaporated to form a biological protein film.
进一步地,步骤S11中所述金属材料为Au、Ag、Al、Pt、Ti、Cu、Cr、TiW中的一种。Further, the metal material in step S11 is one of Au, Ag, Al, Pt, Ti, Cu, Cr, and TiW.
优选地,所述金属材料为Cr或Au,其中,所述Cr和Au厚度均为10nm或100nm。Preferably, the metal material is Cr or Au, wherein the thickness of both Cr and Au is 10 nm or 100 nm.
进一步地,步骤S12中旋涂的所述生物蛋白溶液的浓度范围为1wt%-30wt%,旋涂的转速为500r/min-8000r/min。Further, the concentration range of the biological protein solution spin-coated in step S12 is 1wt%-30wt%, and the rotation speed of the spin-coating is 500r/min-8000r/min.
优选地,所述生物蛋白溶液的浓度7wt%,旋涂的转速为2500r/min。Preferably, the concentration of the biological protein solution is 7wt%, and the rotation speed of the spin coating is 2500r/min.
进一步地,步骤S12中所述生物蛋白膜的厚度范围为10nm-100um。Further, the thickness of the biological protein membrane in step S12 ranges from 10 nm to 100 um.
优选地,所述生物蛋白膜的厚度为100nm。Preferably, the thickness of the biological protein membrane is 100 nm.
具体地,所述基底为Si、GaAs、AlN、Al2O3、ITO、SiO2、SiN、玻璃材料中的一种;Specifically, the substrate is one of Si, GaAs, AlN, Al 2 O 3 , ITO, SiO 2 , SiN, and glass materials;
所述生物蛋白为丝素蛋白、丝胶蛋白、蛛丝蛋白、鹿角蛋白、蛋清蛋白、胶原蛋白中的一种。The biological protein is one of silk fibroin, sericin, spider silk, staghorn, egg white and collagen.
优选地,所述基底为Si片,所述生物蛋白为丝素蛋白。Preferably, the substrate is a Si sheet, and the biological protein is silk fibroin.
一些实施例中,也可以在基底上不蒸发一层金属材料,制备出生物蛋白膜。In some embodiments, a biological protein film can also be prepared without evaporating a layer of metal material on the substrate.
进一步地,所述生物蛋白溶液中可预先掺有功能基团,所述功能基团为生物标记物、DNA、量子点、抗生素、纳米颗粒、生长因子、蛋白酶、抗体中的一种或几种,其中,所述功能基团所占生物蛋白溶液的质量体积比为0.001mg/mL-1g/mL。Further, the biological protein solution can be pre-mixed with functional groups, and the functional groups are one or more of biomarkers, DNA, quantum dots, antibiotics, nanoparticles, growth factors, proteases, and antibodies. , wherein the mass-volume ratio of the functional group to the biological protein solution is 0.001 mg/mL-1 g/mL.
如图8和9所示,所述生物蛋白膜中掺入生物标记物、DNA后,能够储存生物相关信息,所述生物相关信息包含血红蛋白A1、白蛋白A2和葡头糖A3,其中归一化活性标识为S,可以观察到,当经过1天时,血红蛋白A1、白蛋白A2和葡头糖A3三者的归一化活性一样;当经过7天时,三者的归一化活性降低,单白蛋白A2的归一化活性高于血红蛋白A1和葡头糖A3的归一化活性;当经过14天时,三者的归一化活性再次降低,但白蛋白A2的归一化活性依然高于血红蛋白A1和葡头糖A3的归一化活性。As shown in Figures 8 and 9, after incorporating biomarkers and DNA into the biological protein membrane, biologically relevant information can be stored, and the biologically relevant information includes hemoglobin A1, albumin A2 and glucose A3, where normalized It can be observed that the normalized activities of hemoglobin A1, albumin A2 and glucose A3 are the same after 1 day; after 7 days, the normalized activities of the three decrease, and the The normalized activity of albumin A2 was higher than that of hemoglobin A1 and glucosinolate A3; after 14 days, the normalized activity of the three decreased again, but the normalized activity of albumin A2 was still higher than Normalized activity of hemoglobin A1 and glucosinolate A3.
如图10所示,所述生物蛋白膜中掺入抗生素后,能够抗菌,其中,图B1为掺入抗生素后的生物蛋白膜,图B2为未掺入抗生素后的生物蛋白膜,能够看出抗菌效果明显。As shown in Figure 10, the biological protein film can be antibacterial after incorporating antibiotics, wherein, Figure B1 is the biological protein film after incorporating antibiotics, and Figure B2 is the biological protein film without incorporating antibiotics, it can be seen that Antibacterial effect is obvious.
如图11所示,所述生物蛋白膜中掺入蛋白酶后,存储的信息能够可控降解,其中,图D1为未掺木瓜蛋白酶的生物蛋白膜;图D2为掺木瓜蛋白酶的生物蛋白膜;图D3经过50℃水浴处理后,未掺木瓜蛋白酶的生物蛋白膜;图D4经过50℃水浴处理后,掺木瓜蛋白酶的生物蛋白膜;可以观察到,未掺木瓜蛋白酶的生物蛋白膜的信息数量比掺木瓜蛋白酶的生物蛋白膜的信息数量多,在经过50℃水浴处理后,未掺木瓜蛋白酶的生物蛋白膜信息保留,而掺木瓜蛋白酶的生物蛋白膜的信息消除了。As shown in Figure 11, after incorporating protease into the biological protein membrane, the stored information can be degraded in a controllable manner, wherein, Figure D1 is the biological protein membrane without papain; Figure D2 is the biological protein membrane doped with papain; Figure D3, after being treated in a 50°C water bath, the bioprotein film without papain; Figure D4, after being treated in a 50°C water bath, the bioprotein film with papain; it can be observed that the information quantity of the bioprotein film without papain Compared with the papain-doped biological protein membrane, the information quantity is more. After being treated in a 50 ℃ water bath, the information of the papain-free biological protein membrane is retained, while the information of the papain-doped biological protein membrane is eliminated.
具体地,步骤S2包括:Specifically, step S2 includes:
将待存储信息按照预设编码形式进行编码,其中,所述预设编码形式为二进制形式。The information to be stored is encoded according to a preset encoding form, wherein the preset encoding form is a binary form.
进一步地,选取一张待存储的图片,通过Winhex软件获得其在计算机里的二进制存储信息。Further, select a picture to be stored, and obtain its binary storage information in the computer through Winhex software.
具体地,步骤S3包括以下步骤:Specifically, step S3 includes the following steps:
S31.采用预设功率的激光源辐射原子力显微镜的针尖,所述激光源辐射频率与所述生物蛋白膜的吸收光谱相对应;S31. Use a laser source of preset power to irradiate the needle tip of an atomic force microscope, and the radiation frequency of the laser source corresponds to the absorption spectrum of the biological protein membrane;
S32.移动所述生物蛋白膜,在所述生物蛋白膜上直写编码后的信息对应的点阵结构。S32. Move the biological protein membrane, and directly write the lattice structure corresponding to the encoded information on the biological protein membrane.
进一步地,步骤S31中所述激光源辐射的激光瞬时功率范围为0.01mW-100W。Further, the instantaneous laser power radiated by the laser source in step S31 ranges from 0.01mW to 100W.
优选地,所述激光源辐射的激光瞬时功率为300mW,同时所述激光源辐射的激光波长为6.06μm。Preferably, the instantaneous laser power radiated by the laser source is 300 mW, and the laser wavelength radiated by the laser source is 6.06 μm.
进一步地,采用预设功率的激光源辐射原子力显微镜的针尖,主要用于引起原子力显微镜针尖下方的生物蛋白形貌发生变化,这种变化趋势是由平整变为凸起点。Further, using a laser source with preset power to irradiate the tip of the atomic force microscope is mainly used to cause the topography of the biological protein under the tip of the atomic force microscope to change, and the change trend is from flat to raised point.
进一步地,步骤S31中所述生物蛋白膜的吸收光谱包含两种吸收峰,一种吸收峰是未交联的丝素蛋白吸收峰,其在1650cm-1处;另一种吸收峰是交联的丝素蛋白吸收峰,其在1625cm-1处。Further, the absorption spectrum of the biological protein membrane in step S31 contains two absorption peaks, one absorption peak is the uncrosslinked silk fibroin absorption peak, which is at 1650 cm −1 ; the other absorption peak is the crosslinking peak. The absorption peak of silk fibroin is at 1625cm -1 .
进一步地,所述激光源辐射频率与所述生物蛋白膜的吸收光谱可相对应也可不相对应。Further, the radiation frequency of the laser source may or may not correspond to the absorption spectrum of the biological protein film.
进一步地,步骤S31中所述原子力显微镜处于轻敲模式。Further, the atomic force microscope in step S31 is in a tapping mode.
进一步地,步骤S32中移动所述生物蛋白膜的速率为10nm/ms-10μm/ms。Further, the speed of moving the biological protein membrane in step S32 is 10 nm/ms-10 μm/ms.
结合图4和图5所示,步骤S32中在所述点阵结构内规定所述生物蛋白膜上的凸起点为“1”,非凸起点为“0”,与步骤S2中所述预设编码形式相对应。As shown in FIG. 4 and FIG. 5 , in step S32, the raised points on the biological protein membrane are specified as "1" and the non-raised points as "0" in the lattice structure, which is the same as the preset in step S2. Corresponding to the encoding form.
优选地,以100nm为间隔周期,设置所述点阵结构中的所述生物蛋白膜上的凸起点和非凸起点。Preferably, the raised points and the non-raised points on the biological protein membrane in the lattice structure are arranged at intervals of 100 nm.
具体地,在步骤S32之后,所述方法还包括:Specifically, after step S32, the method further includes:
对存储于所述生物蛋白膜中的信息进行解码,读取存储于所述生物蛋白膜中的信息。Decoding the information stored in the biological protein membrane, and reading the information stored in the biological protein membrane.
进一步地,所述对存储于所述生物蛋白膜中的信息进行解码,读取存储于所述生物蛋白膜中的信息包括:Further, decoding the information stored in the biological protein membrane, and reading the information stored in the biological protein membrane includes:
采用原子力显微镜扫描所述点阵结构,对所述点阵结构中的信息进行解码,读取所述点阵结构中的信息,其中,也以100nm为间隔周期,对原子力显微镜扫描后的所述点阵结构中所述生物蛋白膜上的凸起点和非凸起点进行设置,进而读取所述点阵结构中的信息。The lattice structure is scanned by an atomic force microscope, the information in the lattice structure is decoded, and the information in the lattice structure is read. The raised dots and non-raised dots on the biological protein membrane in the lattice structure are set, and then the information in the lattice structure is read.
如图12所示,可以观察到,基于生物蛋白的信息存储方法,能够耐受高温、高湿度、辐照、磁场等恶劣条件,其中,BP为处理前的曲线,AP为处理后的曲线。As shown in Figure 12, it can be observed that the information storage method based on biological protein can withstand harsh conditions such as high temperature, high humidity, irradiation, magnetic field, etc., where BP is the curve before processing, and AP is the curve after processing.
本实施例一提供了一种基于生物蛋白的信息存储方法,能够存储生物信息,能够原位“写入”和“读取”数字化信息。The first embodiment provides an information storage method based on biological proteins, which can store biological information, and can "write" and "read" digital information in situ.
实施例二Embodiment 2
本实施例二提供了一种基于生物蛋白的信息存储方法,结合图1、图2和图3所示,包括以下步骤:The second embodiment provides a biological protein-based information storage method, which is shown in FIG. 1 , FIG. 2 and FIG. 3 , and includes the following steps:
S1.制备掺杂或未掺杂功能基团的生物蛋白膜;S1. Preparation of biological protein membranes doped or undoped with functional groups;
S2.对待存储信息进行编码;S2. Encode the information to be stored;
S3.将编码后的信息以及功能基团中的信息存储于所述生物蛋白膜中。S3. Store the encoded information and the information in the functional group in the biological protein membrane.
具体地,步骤S1包括以下步骤:Specifically, step S1 includes the following steps:
S11.在基底上蒸发一层金属材料;S11. Evaporate a layer of metal material on the substrate;
S12.在蒸发有所述金属材料的基底上旋涂一层生物蛋白溶液,形成生物蛋白膜。S12. Spin coating a layer of biological protein solution on the substrate on which the metal material is evaporated to form a biological protein film.
进一步地,步骤S11中所述金属材料为Au、Ag、Al、Pt、Ti、Cu、Cr、TiW中的一种。Further, the metal material in step S11 is one of Au, Ag, Al, Pt, Ti, Cu, Cr, and TiW.
优选地,所述金属材料为Cr或Au,其中,所述Cr和Au厚度均为10nm或100nm。Preferably, the metal material is Cr or Au, wherein the thickness of both Cr and Au is 10 nm or 100 nm.
进一步地,步骤S12中旋涂的所述生物蛋白溶液的浓度范围为1wt%-30wt%,旋涂的转速为500r/min-8000r/min。Further, the concentration range of the biological protein solution spin-coated in step S12 is 1wt%-30wt%, and the rotation speed of the spin-coating is 500r/min-8000r/min.
优选地,所述生物蛋白溶液的浓度7wt%,旋涂的转速为2500r/min。Preferably, the concentration of the biological protein solution is 7 wt %, and the rotation speed of the spin coating is 2500 r/min.
进一步地,步骤S12中所述生物蛋白膜的厚度范围为10nm-100um。Further, the thickness of the biological protein membrane in step S12 ranges from 10 nm to 100 um.
优选地,所述生物蛋白膜的厚度为100nm。Preferably, the thickness of the biological protein membrane is 100 nm.
具体地,所述基底为Si、GaAs、AlN、Al2O3、ITO、SiO2、SiN、玻璃材料中的一种;Specifically, the substrate is one of Si, GaAs, AlN, Al 2 O 3 , ITO, SiO 2 , SiN, and glass materials;
所述生物蛋白为丝素蛋白、丝胶蛋白、蛛丝蛋白、鹿角蛋白、蛋清蛋白、胶原蛋白中的一种。The biological protein is one of silk fibroin, sericin, spider silk, staghorn, egg white and collagen.
优选地,所述基底为Si片,所述生物蛋白为丝素蛋白。Preferably, the substrate is a Si sheet, and the biological protein is silk fibroin.
一些实施例中,也可以在基底上不蒸发一层金属材料,制备出生物蛋白膜。In some embodiments, a biological protein film can also be prepared without evaporating a layer of metal material on the substrate.
进一步地,所述生物蛋白溶液中可预先掺有功能基团,所述功能基团为生物标记物、DNA、量子点、抗生素、纳米颗粒、生长因子、蛋白酶、抗体中的一种或几种,其中,所述功能基团所占生物蛋白溶液的质量体积比为0.001mg/mL-1g/mL。Further, the biological protein solution can be pre-mixed with functional groups, and the functional groups are one or more of biomarkers, DNA, quantum dots, antibiotics, nanoparticles, growth factors, proteases, and antibodies. , wherein the mass-volume ratio of the functional group to the biological protein solution is 0.001 mg/mL-1 g/mL.
如图8和9所示,所述生物蛋白膜中掺入生物标记物、DNA后,能够储存生物相关信息,所述生物相关信息包含血红蛋白A1、白蛋白A2和葡头糖A3,其中归一化活性标识为S,可以观察到,当经过1天时,血红蛋白A1、白蛋白A2和葡头糖A3三者的归一化活性一样;当经过7天时,三者的归一化活性降低,单白蛋白A2的归一化活性高于血红蛋白A1和葡头糖A3的归一化活性;当经过14天时,三者的归一化活性再次降低,但白蛋白A2的归一化活性依然高于血红蛋白A1和葡头糖A3的归一化活性。As shown in Figures 8 and 9, after incorporating biomarkers and DNA into the biological protein membrane, biologically relevant information can be stored, and the biologically relevant information includes hemoglobin A1, albumin A2 and glucose A3, where normalized It can be observed that the normalized activities of hemoglobin A1, albumin A2 and glucose A3 are the same after 1 day; after 7 days, the normalized activities of the three decrease, and the The normalized activity of albumin A2 was higher than that of hemoglobin A1 and glucosinolate A3; after 14 days, the normalized activity of the three decreased again, but the normalized activity of albumin A2 was still higher than Normalized activity of hemoglobin A1 and glucosinolate A3.
如图10所示,所述生物蛋白膜中掺入抗生素后,能够抗菌,其中,图B1为掺入抗生素后的生物蛋白膜,图B2为未掺入抗生素后的生物蛋白膜,能够看出抗菌效果明显。As shown in Figure 10, the biological protein film can be antibacterial after incorporating antibiotics, wherein, Figure B1 is the biological protein film after incorporating antibiotics, and Figure B2 is the biological protein film without incorporating antibiotics, it can be seen that Antibacterial effect is obvious.
如图11所示,所述生物蛋白膜中掺入蛋白酶后,存储的信息能够可控降解,其中,图D1为未掺木瓜蛋白酶的生物蛋白膜;图D2为掺木瓜蛋白酶的生物蛋白膜;图D3经过50℃水浴处理后,未掺木瓜蛋白酶的生物蛋白膜;图D4经过50℃水浴处理后,掺木瓜蛋白酶的生物蛋白膜;可以观察到,未掺木瓜蛋白酶的生物蛋白膜的信息数量比掺木瓜蛋白酶的生物蛋白膜的信息数量多,在经过50℃水浴处理后,未掺木瓜蛋白酶的生物蛋白膜信息保留,而掺木瓜蛋白酶的生物蛋白膜的信息消除了。As shown in Figure 11, after incorporating protease into the biological protein membrane, the stored information can be degraded in a controllable manner, wherein, Figure D1 is the biological protein membrane without papain; Figure D2 is the biological protein membrane doped with papain; Figure D3, after being treated in a 50°C water bath, the bioprotein film without papain; Figure D4, after being treated in a 50°C water bath, the bioprotein film with papain; it can be observed that the information quantity of the bioprotein film without papain Compared with the papain-doped biological protein membrane, the information quantity is more. After being treated in a 50 ℃ water bath, the information of the papain-free biological protein membrane is retained, while the information of the papain-doped biological protein membrane is eliminated.
具体地,步骤S2包括:Specifically, step S2 includes:
将待存储信息按照预设编码形式进行编码,其中,所述预设编码形式为二进制形式。The information to be stored is encoded according to a preset encoding form, wherein the preset encoding form is a binary form.
进一步地,选取一张待存储的图片,通过Winhex软件获得其在计算机里的二进制存储信息。Further, select a picture to be stored, and obtain its binary storage information in the computer through Winhex software.
具体地,步骤S3包括以下步骤:Specifically, step S3 includes the following steps:
S31.采用预设功率的激光源辐射原子力显微镜的针尖,所述激光源辐射频率与所述生物蛋白膜的吸收光谱相对应;S31. Use a laser source of preset power to irradiate the needle tip of an atomic force microscope, and the radiation frequency of the laser source corresponds to the absorption spectrum of the biological protein membrane;
S32.移动所述生物蛋白膜,在所述生物蛋白膜上直写编码后的信息对应的点阵结构。S32. Move the biological protein membrane, and directly write the lattice structure corresponding to the encoded information on the biological protein membrane.
进一步地,步骤S31中所述激光源辐射的激光瞬时功率范围为0.01mW-100W。Further, the instantaneous laser power radiated by the laser source in step S31 ranges from 0.01mW to 100W.
优选地,所述激光源辐射的激光瞬时功率为300mW,同时所述激光源辐射的激光波长为6.06μm。Preferably, the instantaneous laser power radiated by the laser source is 300 mW, and the laser wavelength radiated by the laser source is 6.06 μm.
进一步地,采用预设功率的激光源辐射原子力显微镜的针尖,主要用于引起原子力显微镜针尖下方的生物蛋白形貌发生变化,这种变化趋势是由平整变为凸起点。Further, using a laser source with a preset power to irradiate the tip of the atomic force microscope is mainly used to cause the topography of the biological protein below the tip of the atomic force microscope to change, and the change trend is from flat to raised point.
进一步地,步骤S31中所述生物蛋白膜的吸收光谱包含两种吸收峰,一种吸收峰是未交联的丝素蛋白吸收峰,其在1650cm-1处;另一种吸收峰是交联的丝素蛋白吸收峰,其在1625cm-1处。Further, the absorption spectrum of the biological protein membrane in step S31 contains two absorption peaks, one absorption peak is the uncrosslinked silk fibroin absorption peak, which is at 1650 cm −1 ; the other absorption peak is the crosslinking peak. The absorption peak of silk fibroin is at 1625cm -1 .
进一步地,所述激光源辐射频率与所述生物蛋白膜的吸收光谱可相对应也可不相对应。Further, the radiation frequency of the laser source may or may not correspond to the absorption spectrum of the biological protein film.
进一步地,步骤S31中所述原子力显微镜处于轻敲模式。Further, the atomic force microscope in step S31 is in a tapping mode.
进一步地,步骤S32中移动所述生物蛋白膜的速率为10nm/ms-10μm/ms。Further, the speed of moving the biological protein membrane in step S32 is 10 nm/ms-10 μm/ms.
进一步地,步骤S32中在所述点阵结构内规定所述生物蛋白膜上的凸起点为“1”,非凸起点为“0”,与步骤S2中所述预设编码形式相对应。Further, in the step S32, the raised dots on the biological protein membrane are specified as "1" and the non-raised dots are defined as "0" in the lattice structure, which corresponds to the preset encoding form in the step S2.
优选地,以100nm为间隔周期,设置所述点阵结构中的所述生物蛋白膜上的凸起点和非凸起点,如图6所示,分两排写入16个点,编码分别为“11111111”和“11111111”。Preferably, with an interval of 100 nm, set the raised points and non-raised points on the biological protein membrane in the lattice structure, as shown in Figure 6, write 16 points in two rows, the codes are "" 11111111" and "11111111".
具体地,在步骤S32之后,所述方法还包括:Specifically, after step S32, the method further includes:
对存储于所述生物蛋白膜中的信息进行擦除,重写存储于所述生物蛋白膜中的信息。The information stored in the biological protein membrane is erased, and the information stored in the biological protein membrane is rewritten.
进一步地,所述对存储于所述生物蛋白膜中的信息进行擦除,重写存储于所述生物蛋白膜中的信息包括:Further, erasing the information stored in the biological protein membrane, and rewriting the information stored in the biological protein membrane includes:
采用小于或大于所述预设功率的红外激光源辐射原子力显微镜的针尖,对所述点阵结构进行消除,Using an infrared laser source with a power smaller than or greater than the preset power to irradiate the tip of the atomic force microscope to eliminate the lattice structure,
采用所述预设功率的红外激光源辐射原子力显微镜的针尖,重写所述点阵结构。Using the infrared laser source with the preset power to irradiate the tip of an atomic force microscope, the lattice structure is rewritten.
进一步地,所述预设功率由小变大时,所述点阵结构中由凸起点变为凹坑,反之亦然。Further, when the preset power changes from low to high, the dot matrix structure changes from raised points to pits, and vice versa.
优选地,如图7所示,查询得到字母“U”和“T”的ASCII编码分别为“01010101”和“01010100”。加大激光源辐射的瞬时功率至1W,将对所述点阵结构进行消除相应位置的点擦除,即由“1”变为“0”,得到“U”和“T”的ASCII编码“01010101”和“01010100”,实现消除。Preferably, as shown in FIG. 7 , the ASCII codes of the letters "U" and "T" obtained from the query are "01010101" and "01010100", respectively. Increase the instantaneous power of the laser source radiation to 1W, the dot matrix structure will be erased to eliminate the corresponding position, that is, from "1" to "0", the ASCII codes of "U" and "T" are obtained" 01010101" and "01010100" to achieve elimination.
进一步地,在对上述已经消除的所述点阵结构以100nm为间隔周期,对原子力显微镜扫描后的所述点阵结构中所述生物蛋白膜上的凸起点和非凸起点进行设置,进而读取所述点阵结构中的信息。Further, in the above-mentioned lattice structure that has been eliminated, with an interval of 100 nm, the raised points and non-raised points on the biological protein film in the lattice structure after the atomic force microscope scanning are set, and then read. Take the information in the lattice structure.
如图12所示,可以观察到,基于生物蛋白的信息存储方法,能够耐受高温、高湿度、辐照、磁场等恶劣条件,其中,BP为处理前的曲线,AP为处理后的曲线。As shown in Figure 12, it can be observed that the biological protein-based information storage method can withstand harsh conditions such as high temperature, high humidity, irradiation, and magnetic fields, where BP is the curve before processing, and AP is the curve after processing.
本实施例二提供了一种基于生物蛋白的信息存储方法,能够实现数字化信息的重复写入或擦除。The second embodiment provides an information storage method based on biological proteins, which can realize repeated writing or erasing of digital information.
上述说明已经充分揭露了本发明的具体实施方式。需要指出的是,熟悉该领域的技术人员对本发明的具体实施方式所做的任何改动均不脱离本发明的权利要求书的范围。相应地,本发明的权利要求的范围也并不仅仅局限于前述具体实施方式。The foregoing description has fully disclosed specific embodiments of the present invention. It should be pointed out that any changes made by those skilled in the art to the specific embodiments of the present invention will not depart from the scope of the claims of the present invention. Accordingly, the scope of the claims of the present invention is not limited to the foregoing specific embodiments.
Claims (13)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010500300.1A CN111724841B (en) | 2020-06-04 | 2020-06-04 | An information storage method based on biological protein |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010500300.1A CN111724841B (en) | 2020-06-04 | 2020-06-04 | An information storage method based on biological protein |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN111724841A CN111724841A (en) | 2020-09-29 |
| CN111724841B true CN111724841B (en) | 2022-06-10 |
Family
ID=72566079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010500300.1A Active CN111724841B (en) | 2020-06-04 | 2020-06-04 | An information storage method based on biological protein |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111724841B (en) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0822861B1 (en) * | 1995-04-25 | 2003-11-26 | Discovery Partners International, Inc. | Remotely programmable matrices with memories and uses thereof |
| CN100349178C (en) * | 2004-12-06 | 2007-11-14 | 中国科学院大连化学物理研究所 | Micro flow controlling chip DNA molecular memory |
| TW201330281A (en) * | 2012-01-12 | 2013-07-16 | Nat Univ Tsing Hua | Organic floating gate memory device having protein and method of fabricating the same |
| CN105633112A (en) * | 2015-12-30 | 2016-06-01 | 西安电子科技大学 | Super-light resistive random access memory and preparation method thereof |
| KR102622275B1 (en) * | 2017-01-10 | 2024-01-05 | 로스웰 바이오테크놀로지스 인코포레이티드 | Methods and systems for DNA data storage |
| CN106527045A (en) * | 2017-01-20 | 2017-03-22 | 中国科学院上海微系统与信息技术研究所 | Optical component-based method for information hiding and reproduction |
| CA3054303A1 (en) * | 2017-02-22 | 2018-08-30 | Twist Bioscience Corporation | Nucleic acid based data storage |
| CN107331773B (en) * | 2017-06-28 | 2019-06-25 | 深圳大学 | A kind of degradable albumen based transistor type memory and preparation method thereof |
-
2020
- 2020-06-04 CN CN202010500300.1A patent/CN111724841B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN111724841A (en) | 2020-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lee et al. | A rewritable optical storage medium of silk proteins using near-field nano-optics | |
| Terris et al. | Near‐field optical data storage using a solid immersion lens | |
| Zhong et al. | Self‐assembly of regenerated silk fibroin from random coil nanostructures to antiparallel β‐sheet nanostructures | |
| CN111724841B (en) | An information storage method based on biological protein | |
| CN106398208B (en) | A kind of photosensitive composite film material, preparation method and application thereof | |
| CN101981500B (en) | Metal optical gray mask and manufacturing method thereof | |
| CN101935014B (en) | A method of linearly controllable preparation of nano-lattice arrays based on laser direct writing of metal thin films | |
| CN118002909A (en) | A method for processing high-precision complex micro-nano structures on the surface of lithium niobate | |
| CN109103213B (en) | A hair-based flexible optical logic gate and its manufacturing method | |
| Yamamoto et al. | Super-resolution optical disc with high readout stability using a zinc oxide thin film | |
| CN109324473B (en) | A photolithography mask and preparation method thereof | |
| CN100358031C (en) | Optical recording disc | |
| CN114883516B (en) | Fluorescent film patterning method based on laser ablation and application thereof | |
| CN106227000B (en) | The nano-photoetching method of induced with laser transient state thermal probe | |
| CN112368297B (en) | Amyloid-based foundation building materials with integrated gene programmable functions | |
| CN100428349C (en) | New uses of photochromic diarylene compounds | |
| CN118366487A (en) | Method for storing data and optical memory | |
| CN119296594B (en) | Preparation method of optical information storage device and storage device | |
| CN111547760B (en) | Preparation method and application of oxide substrate in-situ growth silver nanorod | |
| CN111122431B (en) | Self-assembly model and preparation method thereof, and self-assembly method of phototunable friction coefficient thin film | |
| CN119143402A (en) | Bacterial-embedded micro-nano structure substrate and preparation method and application thereof | |
| CN116125572A (en) | Super-resolution microscope surface plasmon lens and preparation method thereof | |
| Zhou et al. | Rewritable Optical Storage Medium of Silk Proteins Using Tip-Based Nanolithography | |
| Beecroft | Advanced nanocomposite materials for optical applications | |
| CN120399287A (en) | A method for preparing nanocellulose-based photonic crystal film |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |